Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metastatic neurologic complications of non-Hodgkin's lymphoma.

Literature DB >> 15610687

Metastatic neurologic complications of non-Hodgkin's lymphoma.

Abstract

Neurologic complications of non-Hodgkin's lymphoma represent challenging diagnostic and therapeutic issues. Leptomeningeal, epidural, and brain metastases are the most common neurologic complications, and each is associated with a poor prognosis. However, early recognition and intervention often result in improved quality of life and, for a subset of patients, an opportunity for longer survival.

Entities: Disease Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2005 PMID： 15610687 DOI： 10.1007/s11912-005-0026-9

Source DB: PubMed Journal: Curr Oncol Rep ISSN： 1523-3790 Impact factor: 5.075

41 in total

Review 1. Neoplastic meningitis.

Authors: S A Grossman; T J Moynihan
Journal: Neurol Clin Date: 1991-11 Impact factor: 3.806

2. Lymphomatous leptomeningitis.

Authors: J W Griffin; R W Thompson; M J Mitchinson; J C De Kiewiet; F H Welland
Journal: Am J Med Date: 1971-08 Impact factor: 4.965

3. Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia.

Authors: J R Gray; K E Wallner
Journal: Int J Radiat Oncol Biol Phys Date: 1990-08 Impact factor: 7.038

4. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.

Authors: P A Bunn; P S Schein; P M Banks; V T DeVita
Journal: Blood Date: 1976-01 Impact factor: 22.113

5. Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment.

Authors: J Ersbøll; H B Schultz; B L Thomsen; N Keiding; N I Nissen
Journal: Scand J Haematol Date: 1985-11

6. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.

Authors: C Haioun; C Besson; E Lepage; C Thieblemont; D Simon; C Rose; H Tilly; A Sonet; P Lederlin; M Attal; J Brière; F Reyes
Journal: Ann Oncol Date: 2000-06 Impact factor: 32.976

Review 7. Leptomeningeal metastases: a review of evaluation and treatment.

Authors: M C Chamberlain
Journal: J Neurooncol Date: 1998-05 Impact factor: 4.130

8. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

Authors: Naoto Tomita; Fumio Kodama; Heiwa Kanamori; Shigeki Motomura; Yoshiaki Ishigatsubo
Journal: Cancer Date: 2002-08-01 Impact factor: 6.860

9. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.

Authors: E T Wong; C S Portlock; J P O'Brien; L M DeAngelis
Journal: Neurology Date: 1996-06 Impact factor: 9.910

10. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

Authors: S A Grossman; D M Finkelstein; J C Ruckdeschel; D L Trump; T Moynihan; D S Ettinger
Journal: J Clin Oncol Date: 1993-03 Impact factor: 44.544

7 in total

Review 7. Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions.

Authors: Hua You; Szymon Baluszek; Bozena Kaminska
Journal: Theranostics Date: 2020-02-10 Impact factor: 11.556

7 in total

Metastatic neurologic complications of non-Hodgkin's lymphoma.

Review 1. Neoplastic meningitis.

2. Lymphomatous leptomeningitis.

3. Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia.

4. Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.

5. Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment.

6. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.

Review 7. Leptomeningeal metastases: a review of evaluation and treatment.

8. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.

9. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.

10. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

Review 1. Spinal cord compression in cancer patients: review of diagnosis and treatment.

2. Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

3. Rare case of T-cell lymphoma presenting as acute myelopathy.

4. Biopsy-proven mantle cell lymphoma in brain parenchyma.

Review 5. Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?

6. Neurological complication of non Hodgkin lymphoma in childhood: experience from a single center in Turkey.

Review 7. Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions.